Tsarouchi, M., Hoxhaj, A., Portaluri, A., Sung, J., Sechopoulos, I., Pinker-Domenig, K., & Mann, R. M. (2025). Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT. European Journal of Radiology, 185, 112013. https://doi.org/10.1016/j.ejrad.2025.112013

DiMauro, K. A., Heber, M. E., Lee, J., Cohen, J. A., Flanagan, E. P., Riley, C., Goldman, M. D., Zamvil, S. S., & Kunchok, A. C. (2025). Progressive Myelitis in a 63-Year-Old Woman. Neurology Neuroimmunology & Neuroinflammation, 12(2). https://doi.org/10.1212/nxi.0000000000200382

Panagiotis, K., Gullo, R. L., Resch, D., & Pinker, K. (2025). Molecular breast imaging. Die Radiologie, 65(3), 170–177. https://doi.org/10.1007/s00117-024-01403-z

Huang, Y., Kwan, M. L., Heckbert, S. R., Smith, N. L., Othus, M., Laurent, C. A., Roh, J. M., Rillamas-Sun, E., Lee, V. S., Kolevska, T., Cheng, R. K., Irribarren, C., Nguyen-Huynh, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2025). Duration of aromatase inhibitor use and long-term cardiovascular risk in breast cancer survivors. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf009

Teteh-Brooks, D. K., Ericson, M., Bethea, T. N., Dawkins-Moultin, L., Sarkaria, N., Bailey, J., Llanos, A. A. M., & Montgomery, S. (2025). Validating the Black Identity, Hair Product Use, and Breast Cancer Scale (BHBS) Among Black Breast Cancer Survivors. International Journal of Environmental Research and Public Health, 22(2), 174. https://doi.org/10.3390/ijerph22020174

Bhangdia, K., Natarajan, A., Rudolfson, N., Verguet, S., Castro, M. C., Dusengimana, J.-M. V., Shyirambere, C., Schleimer, L. E., Shulman, L. N., Umwizerwa, A., Kigonya, C., Butonzi, J., MacDuffie, E., Fadelu, T., O’Neil, D. S., Nguyen, C., Mpunga, T., Keating, N. L., & Pace, L. E. (2025). The association of travel distance and other patient characteristics with breast cancer stage at diagnosis and treatment completion at a rural Rwandan cancer facility. BMC Cancer, 25(1). https://doi.org/10.1186/s12885-025-13489-2

Dibble, K. E., Rosenberg, S. M., Snow, C., Kirkner, G. J., Tayob, N., Contreras, M., Roma, N. D., DeGraffinreid, C. R., Nolan, T. S., Hershman, D. L., Naughton, M., & Partridge, A. H. (2025). Young, Empowered & strong (YES): a study protocol paper for a randomized controlled trial of an mHealth symptom monitoring and self-management intervention for adolescent and young adult (AYA) breast cancer survivors. BMC Public Health, 25(1). https://doi.org/10.1186/s12889-025-21288-4

McGale, J., Khurana, S., Howell, H., Nakhla, A., Roa, T., Doshi, P., Shirini, D., Huang, A., Duong, P., Backhaus, P., Liao, M., Kaur, H., Fontani, A. M., Hung, I., Pandit-Taskar, N., Haberkorn, U., Gulati, A., Naim, A., Sinigaglia, M., … Dercle, L. (2025). FAP-Targeted SPECT/CT and PET/CT Imaging for Breast Cancer Patients. Clinical Nuclear Medicine. https://doi.org/10.1097/rlu.0000000000005617

Vaynrub, A., Salazar, B., Feng, Y. E., West, H., Michel, A., Umakanth, S., Crew, K. D., & Kukafka, R. (2025). The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making. BMC Cancer, 25(1). https://doi.org/10.1186/s12885-024-13408-x

Ahluwalia, V. S., Doiphode, N., Mankowski, W. C., Cohen, E. A., Pati, S., Pantalone, L., Bakas, S., Brooks, A., Vachon, C. M., Conant, E. F., Gastounioti, A., & Kontos, D. (2024). Volumetric Breast Density Estimation From Three-Dimensional Reconstructed Digital Breast Tomosynthesis Images Using Deep Learning. JCO Clinical Cancer Informatics, 8. https://doi.org/10.1200/cci.24.00103

Terry, M. B., English, D. R., Freudenheim, J. L., Lauby-Secretan, B., & Gapstur, S. M. (2024). Alcohol cessation and breast cancer risk stratified by hormone receptor status. Breast Cancer Research, 26(1). https://doi.org/10.1186/s13058-024-01937-z

MacInnis, R. J., Jenkins, M. A., Milne, R. L., John, E. M., Daly, M. B., Andrulis, I. L., Colonna, S. V., Phillips, K.-A., Le Marchand, L., Newcomb, P. A., Phipps, A. I., Schmit, S. L., Macrae, F. A., Buchanan, D. D., Gallinger, S., Pai, R. K., Samadder, N. J., Giles, G. G., … Terry, M. B. (2024). Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk. JNCI Cancer Spectrum, 9(1). https://doi.org/10.1093/jncics/pkae121

Tehranifar, P., Lee Argov, E. J., Athilat, S., Liao, Y., Wei, Y., White, A. J., O’Brien, K. M., Sandler, D. P., & Terry, M. B. (2024). Longitudinal history of mammographic breast density and breast cancer risk by familial risk, menopausal status, and initial mammographic density level in a high risk cohort: a nested case–control study. Breast Cancer Research, 26(1). https://doi.org/10.1186/s13058-024-01917-3

Wang, F., Zou, Z., Sakla, N., Partyka, L., Rawal, N., Singh, G., Zhao, W., Ling, H., Huang, C., Prasanna, P., & Chen, C. (2025). TopoTxR: A topology-guided deep convolutional network for breast parenchyma learning on DCE-MRIs. Medical Image Analysis, 99, 103373. https://doi.org/10.1016/j.media.2024.103373

Liu, Y., Hossain, M. M., Li, X. J., & Konofagou, E. E. (2025). Amplitude-Modulation Frequency Optimization for Enhancing Harmonic Motion Imaging Performance of Breast Tumors in the Clinic. Ultrasound in Medicine & Biology, 51(1), 169–179. https://doi.org/10.1016/j.ultrasmedbio.2024.09.021

Chen, J., Kehm, R., Yang, W., & Terry, M. B. (2024). Increasing rates of early-onset Luminal A breast cancers correlate with binge drinking patterns. Breast Cancer Research, 26(1). https://doi.org/10.1186/s13058-024-01894-7

Henry, N. L., Unger, J. M., Vaidya, R., Darke, A. K., Skaar, T. C., Fisch, M. J., & Hershman, D. L. (2024). Active symptom monitoring for premenopausal women with breast cancer initiating adjuvant endocrine therapy: Protocol for the SWOG S2010 randomized controlled efficacy trial. Contemporary Clinical Trials, 147, 107712. https://doi.org/10.1016/j.cct.2024.107712

Chen, Y., Alston, C., Asadourian, P., Black, G. G., Rohde, C. H., & Otterburn, D. M. (2024). Reconstruction trends in New York City: A multi-decade, multi-institutional experience before and after the implementation of the Breast Cancer Provider Discussion Law. Journal of Plastic, Reconstructive & Aesthetic Surgery, 99, 221–229. https://doi.org/10.1016/j.bjps.2024.09.029

Wu, H.-C., Lai, Y., Liao, Y., Deyssenroth, M., Miller, G. W., Santella, R. M., & Terry, M. B. (2024). Plasma metabolomics profiles and breast cancer risk. Breast Cancer Research, 26(1). https://doi.org/10.1186/s13058-024-01896-5

Michel, A. M., Yi, H., Amenta, J., Collins, N., Vaynrub, A., Umakanth, S., Anderson, G., Arnold, K., Law, C., Pruthi, S., Sandoval-Leon, A., Shirley, R., Perdekamp, M. G., Colonna, S., Krisher, S., King, T., Yee, L. D., Ballinger, T. J., Braun-Inglis, C., … Kukafka, R. (2024). Use of web-based decision support to improve informed choice for chemoprevention: a qualitative analysis of pre-implementation interviews (SWOG S1904). BMC Medical Informatics and Decision Making, 24(1). https://doi.org/10.1186/s12911-024-02691-0

Swain, M., Miller, M., Cannella, C., Doe, S., Petersen, L., & Bensenhaver, J. (2024). A Retrospective Study of Fertility Counseling and Preservation Rates for Women of Reproductive Age With Breast Care After Integrating a Fertility Specialist Into a Multidisciplinary Tumor Board. Clinical Breast Cancer, 24(8), e764–e771. https://doi.org/10.1016/j.clbc.2024.09.003

El Jurdi, N., Te, H. S., Cao, Q., Napurski, C., Wang, S., Robinson, A., Arora, M., ElHusseini, H., He, F., Niedernhofer, L. J., Thyagarajan, B., Prizment, A., Holtan, S., Blaes, A. H., & Yousefzadeh, M. J. (2024). Frailty and pre-frailty associated with long-term diminished physical performance and quality of life in breast cancer and hematopoietic cell transplant survivors. Aging, 16(18), 12432–12442. https://doi.org/10.18632/aging.206109

Kwan, M. L., Pimentel, N., Izano, M., Iribarren, C., Rana, J. S., Nguyen-Huynh, M., Cheng, R., Laurent, C. A., Lee, V. S., Roh, J. M., Rillamas-Sun, E., Hershman, D. L., Kushi, L. H., Greenlee, H., & Neugebauer, R. (2024). Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLOS ONE, 19(9), e0310531. https://doi.org/10.1371/journal.pone.0310531

Fine, R. E., Gilmore, R. C., Tomkovich, K. R., Dietz, J. R., Berry, M. P., Hernandez, L. E., Columbus, K. S., Seedman, S. A., Fisher, C. S., Han, L. K., Manahan, E. R., Hicks, R. D., Vaidya, R. P., Curcio, L. D., Sevrukov, A. B., Kenler, A. S., Taback, B., Chen, M., Miller, M. E., … Boolbol, S. K. (2024). Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence. Annals of Surgical Oncology, 31(11), 7273–7283. https://doi.org/10.1245/s10434-024-16181-0

Elkefi, S., & Matthews, A. K. (2025). Factors impacting breast cancer survivors’ performance of annual follow-up mammograms: A nationally representative study. Patient Education and Counseling, 130, 108428. https://doi.org/10.1016/j.pec.2024.108428

Jhaveri, K. L., Accordino, M. K., Bedard, P. L., Cervantes, A., Gambardella, V., Hamilton, E., Italiano, A., Kalinsky, K., Krop, I. E., Oliveira, M., Schmid, P., Saura, C., Turner, N. C., Varga, A., Cheeti, S., Hilz, S., Hutchinson, K. E., Jin, Y., Royer-Joo, S., … Juric, D. (2024). Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology, 42(33), 3947–3956. https://doi.org/10.1200/jco.24.00110

Kim, D. K., & Rohde, C. H. (2024). Disaggregation of Asian American, Native Hawaiian, and Pacific Islander populations in postmastectomy breast reconstruction. Journal of Plastic, Reconstructive & Aesthetic Surgery, 96, 58–68. https://doi.org/10.1016/j.bjps.2024.07.002

Zhu, Y., Pei, X., Novaj, A., Setton, J., Bronder, D., Derakhshan, F., Selenica, P., McDermott, N., Orman, M., Plum, S., Subramanyan, S., Braverman, S. H., McMillan, B., Sinha, S., Ma, J., Gazzo, A., Khan, A., Bakhoum, S., Powell, S. N., … Riaz, N. (2024). Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors. Genome Medicine, 16(1). https://doi.org/10.1186/s13073-024-01371-y

McDonald, J. A., Liao, Y., Knight, J. A., John, E. M., Kurian, A. W., Daly, M., Buys, S. S., Huang, Y., Frost, C. J., Andrulis, I. L., Colonna, S. V., Friedlander, M. L., Hopper, J. L., Chung, W. K., Genkinger, J. M., MacInnis, R. J., Terry, M. B., Amor, D., … Zaheed, M. (2024). Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk. JAMA Network Open, 7(8), e2427441. https://doi.org/10.1001/jamanetworkopen.2024.27441

Rosenberg, S. M., Zeng, C., An, A., Ssebyala, S. N., Stein, T., Lombardo, G., Walker, D., Mercurio, A. M., Elreda, L., Taiwo, E., Hershman, D. L., & Pinheiro, L. C. (2024). Characterizing “collateral damage” in men and women with metastatic breast cancer (mBC) from diverse racial and ethnic backgrounds in New York City. Breast Cancer Research and Treatment, 207(1), 129–141. https://doi.org/10.1007/s10549-024-07347-1

Fong, A. J., Llanos, A. A. M., Hudson, S. V., Schmitz, K., Lu, S.-E., Phillips, S. M., & Manne, S. L. (2024). Online-delivered resistance exercise intervention among racially diverse breast cancer survivors: Feasibility, acceptability, and exploratory outcomes of B-REP. Supportive Care in Cancer, 32(8). https://doi.org/10.1007/s00520-024-08769-9

Broadbridge, E., Greene, K., Venetis, M. K., Lee, L. E., Banerjee, S. C., Buckley de Meritens, A., Catona, D., & Devine, K. A. (2023). The Influence of Perceived Provider Empathic Communication on Disclosure Decision-Making. Health Communication, 39(9), 1807–1824. https://doi.org/10.1080/10410236.2023.2243409

Carter, J., Pugh, S. L., Arring, N., Littell, R. D., Page, S. J., Rowland Jr., K. M., Goodman, J. R., Razaq, W., Siddique, S., Borges, M., Kachnic, L. A., & Barton, D. L. (2024). NRG-CC004 ancillary data study—exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms. The Journal of Sexual Medicine, 21(8), 709–715. https://doi.org/10.1093/jsxmed/qdae061

Sathe, C., Accordino, M. K., DeStephano, D., Shah, M., Wright, J. D., & Hershman, D. L. (2024). Disparities in PI3K/mTOR inhibitor use, toxicities, and outcomes among patients with metastatic breast cancer. Breast Cancer Research and Treatment, 206(3), 519–526. https://doi.org/10.1007/s10549-024-07337-3

Kambalapalli, S., Baral, N., Paul, T. K., Upreti, P., Talaei, F., Ayad, S., Ibrahim, M., Aggarwal, V., Kumar, G., Alraies, C., & Mitchell, J. (2024). Thirty-day hospital readmission in females with acute heart failure and breast cancer: A retrospective cohort study from national readmission database. PLOS ONE, 19(7), e0301596. https://doi.org/10.1371/journal.pone.0301596

Tai, Y., Chow, A., Han, S., Coker, C., Ma, W., Gu, Y., Estrada Navarro, V., Kandpal, M., Hibshoosh, H., Kalinsky, K., Manova-Todorova, K., Safonov, A., Walsh, E. M., Robson, M., Norton, L., Baer, R., Merghoub, T., Biswas, A. K., & Acharyya, S. (2024). FLT1 activation in cancer cells promotes PARP-inhibitor resistance in breast cancer. EMBO Molecular Medicine, 16(8), 1957–1980. https://doi.org/10.1038/s44321-024-00094-2

Crew, K. D., Anderson, G. L., Arnold, K. B., Stieb, A. P., Amenta, J. N., Collins, N., Law, C. W., Pruthi, S., Sandoval-Leon, A., Bertoni, D., Grosse Perdekamp, M. T., Colonna, S., Krisher, S., King, T., Yee, L. D., Ballinger, T. J., Braun-Inglis, C., Mangino, D., Wisinski, K. B., … Kukafka, R. (2024). Making Informed Choices On Incorporating Chemoprevention into carE (MiCHOICE, SWOG 1904): Design and methods of a cluster randomized controlled trial. Contemporary Clinical Trials, 142, 107564. https://doi.org/10.1016/j.cct.2024.107564

Resch, D., Lo Gullo, R., Teuwen, J., Semturs, F., Hummel, J., Resch, A., & Pinker, K. (2024). AI-enhanced Mammography With Digital Breast Tomosynthesis for Breast Cancer Detection: Clinical Value and Comparison With Human Performance. Radiology: Imaging Cancer, 6(4). https://doi.org/10.1148/rycan.230149

Llanos, A. A. M., Ashrafi, A., Olisa, T., Rockson, A., Schaefer, A., McDonald, J. A., Terry, M. B., Teteh-Brooks, D. K., Duncan, D. T., Irungu, B., Kimani, C., & Matu, E. (2024). Hair Dye and Relaxer Use among Cisgender Women in Embu and Nakuru Counties, Kenya: Associations with Perceived Risk of Breast Cancer and Other Health Effects. International Journal of Environmental Research and Public Health, 21(7), 846. https://doi.org/10.3390/ijerph21070846

Therapeutic Efficacy, Safety and Predictive Indicators of Eribulin Plus Anti-Angiogenic Medicine for Metastatic Breast Cancer. (2024). Journal of the College of Physicians and Surgeons Pakistan, 34(06), 682–687. https://doi.org/10.29271/jcpsp.2024.06.682

Kontos, D. (2024). The promise of AI in personalized breast cancer screening: are we there yet? Nature Reviews Clinical Oncology, 21(6), 403–404. https://doi.org/10.1038/s41571-024-00877-z

McGuinness, J. E., Anderson, G. L., Mutasa, S., Hershman, D. L., Terry, M. B., Tehranifar, P., Lew, D. L., Yee, M., Brown, E. A., Kairouz, S. S., Kuwajerwala, N., Bevers, T. B., Doster, J. E., Zarwan, C., Kruper, L., Minasian, L. M., Ford, L., Arun, B., Neuhouser, M. L., … Crew, K. D. (2024). Effects of vitamin D supplementation on a deep learning–based mammographic evaluation in SWOG S0812. JNCI Cancer Spectrum, 8(4). https://doi.org/10.1093/jncics/pkae042

Zanti, M., O’Mahony, D. G., Parsons, M. T., Li, H., Dennis, J., Aittomäkkiki, K., Andrulis, I. L., Anton-Culver, H., Aronson, K. J., Augustinsson, A., Becher, H., Bojesen, S. E., Bolla, M. K., Brenner, H., Brown, M. A., Buys, S. S., Canzian, F., Caputo, S. M., Castelao, J. E., … Michailidou, K. (2023). A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2. Human Mutation, 2023, 1–17. https://doi.org/10.1155/2023/9961341

Lee Argov, E. J., Rodriguez, C. B., Agovino, M., Schmitt, K. M., Desperito, E., Karr, A. G., Wei, Y., Terry, M. B., & Tehranifar, P. (2024). Screening mammography frequency following dense breast notification among a predominantly Hispanic/Latina screening cohort. Cancer Causes & Control, 35(8), 1133–1142. https://doi.org/10.1007/s10552-024-01871-7

Oleru, O. O., Seyidova, N., Taub, P. J., & Rohde, C. H. (2024). Out-of-Pocket Costs and Payments in Autologous and Implant-Based Breast Reconstruction. Annals of Plastic Surgery, 92(4S), S262–S266. https://doi.org/10.1097/sap.0000000000003864

Chen, Y., Alston, C., Chadab, T. M., Asadourian, P., Black, G. G., Rohde, C. H., & Otterburn, D. M. (2024). Comparative Analysis of Recurrence-Free Survival and Mortality in Postmastectomy Patients. Annals of Plastic Surgery, 92(4S), S105–S111. https://doi.org/10.1097/sap.0000000000003858

Yuan, H., Kehm, R. D., Daaboul, J. M., Lloyd, S. E., McDonald, J. A., Mu, L., Tehranifar, P., Zhang, K., Terry, M. B., & Yang, W. (2024). Cancer incidence trends in New York State and associations with common population-level exposures 2010–2018: an ecological study. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-56634-w

Corpuz, G. S., Kim, D. K., Kim, I. E., & Rohde, C. H. (2024). Existing Psychiatric Diagnoses Among Breast Cancer Patients Interact with Outcomes After Autologous and Implant-Based Bilateral Breast Reconstruction: A Propensity Score Matched Analysis. Clinical Breast Cancer, 24(6), e474-e484.e1. https://doi.org/10.1016/j.clbc.2024.03.010

Pinheiro, L. C., An, A., Zeng, C., Walker, D., Mercurio, A. M., Hershman, D. L., & Rosenberg, S. M. (2024). Racial and Ethnic Differences in Psychosocial Care Use Among Adults With Metastatic Breast Cancer: A Retrospective Analysis Across Six New York City Health Systems. JCO Oncology Practice, 20(7), 984–991. https://doi.org/10.1200/op.23.00528

Aiello Bowles, E. J., Kroenke, C. H., Chubak, J., Bhimani, J., O’Connell, K., Brandzel, S., Valice, E., Doud, R., Theis, M. K., Roh, J. M., Heon, N., Persaud, S., Griggs, J. J., Bandera, E. V., Kushi, L. H., & Kantor, E. D. (2023). Evaluation of Algorithms Using Automated Health Plan Data to Identify Breast Cancer Recurrences. Cancer Epidemiology, Biomarkers & Prevention, 33(3), 355–364. https://doi.org/10.1158/1055-9965.epi-23-0782